Log in to save to my catalogue

P3 A single centre real world experience comparing the use of fidaxomicin with vancomycin in the tre...

P3 A single centre real world experience comparing the use of fidaxomicin with vancomycin in the tre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3186594012

P3 A single centre real world experience comparing the use of fidaxomicin with vancomycin in the treatment of clostrioides difficile infection

About this item

Full title

P3 A single centre real world experience comparing the use of fidaxomicin with vancomycin in the treatment of clostrioides difficile infection

Publisher

London: BMJ Publishing Group LTD

Journal title

Gut, 2024-06, Vol.73 (Suppl 1), p.A51-A52

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

IntroductionClostrioides difficile infection was at a 9-year high in the UK in 2021–22. Fidaxomicin is a narrow spectrum antibiotic which has been recommended by NICE for the treatment of vancomycin nonresponsive Clostrioides difficile infection (CDI) and for relapses in CDI. There is limited post marketing surveillance data and real world experien...

Alternative Titles

Full title

P3 A single centre real world experience comparing the use of fidaxomicin with vancomycin in the treatment of clostrioides difficile infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3186594012

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3186594012

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2024-BSG.85

How to access this item